The Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency’s (EMEA) advisory panel, has recommended against the extended use of Sanofi Aventis´ drug Taxotere as an HER2 positive breast cancer treatment, the London-based watchdog announced.

An EMEA advisory panel has recommended against approval of Takeda Pharmaceutical’s insomnia drug Ramelteon for adults. This is yet another blow to the Japan-based drugmaker, who is seeking to compete against Sanofi Aventis’ sleep aid drug Ambien

The European Medicines Agency (EMEA) recommended that Millennium Pharmaceuticals’ cancer drug injection Velcade (bortezomib) should not be used in patients with certain severe pulmonary or heart problems. Treatment had already been approved in the U.S. and Europe for patients with multiple myeloma who have received at least one prior therapy

U.S. regulators have rejected Daiichi Sankyo Co injectable anaemia drug Injectafer for the broad treatment of uterine bleeding. Also, the FDA Advisory Panel had voted in February against recommending broad use of the drug but said the benefits outweighed the risks for women who could not tolerate oral iron or had an unsatisfactory response to it.